Feature|Videos|June 21, 2024
Cultural Transformations a Necessity to Support Complex Therapeutics Through Development and Manufacturing
Author(s)Pii
President and CEO of Pharmaceutics International, Inc. (Pii), John Fowler, reacts to the agility and flexibility needed to support the development and manufacture of today's complex biotherapeutics.
Watch the video and learn more about:
- Services necessary to carry out new programs for complex molecules, from scale-up to commercialization.
- Lyophilization capabilities that can help ensure quality through processing.
- Resources to support efficient secondary pharmaceutical packaging.
Related Content
Trending on Pharmaceutical Technology
1
What Jideytro's Approval Means for Drug Developers
2
Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data
3
Peptide Compounding Vote Raises New Questions for Drug Developers
4
Midyear 2026 Check-In: AI Investment Skipped Pharma's Costliest Operational Problem
5